A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

Study Overview

This trial will study putative therapeutics in a hospitalized population with moderate to severe COVID-19.

Study Description

Participants will be randomly assigned to receive placebo or an experimental study drug.


  • IRB Number: 2005800939
  • Research Study Identifier: 2005800939
  • Principal Investigator: Samir Gupta, MD

Recruitment Status

Enrolling By Invitation

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.